Clinical Trials Directory

Trials / Completed

CompletedNCT03826615

Gabapentin Pretreatment for Staged Bilateral Cataract Operations

The Effect of Gabapentin Pretreatment on Hyperalgesia in Elderly Patients Undergoing Staged Bilateral Cataract Operations

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

To evaluate the effect of oral gabapentin premedication on hyperalgesia in elderly patients undergoing staged bilateral cataract operations under monitored anesthesia care

Detailed description

It has been reported that patients with bilateral cataract complained more pain and discomfort during the second consecutive eye surgery compared to the first eye surgery. Gabapentin is an anticonvulsant drug, which has been extended the use to perioperative analgesia, and anxiolysis. Therefore, the investigators conducted this randomized, controlled study to evaluate the effects of gabapentin premedication on patients' subjective sensations, including intraoperative anxiety, perceptions of pain, and light sensitivity, in the second cataract operations.

Conditions

Interventions

TypeNameDescription
DRUGGabapentinPatients receive gabapentin 100mg orally for 3 times a day during the period of first and second cataract operations

Timeline

Start date
2019-02-01
Primary completion
2020-01-03
Completion
2020-01-03
First posted
2019-02-01
Last updated
2020-11-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03826615. Inclusion in this directory is not an endorsement.